David Larkin is listed as an executive officer on 2 SEC Form D filings by 1 issuer between Mar 2022 and Nov 2023: RefleXion Medical, Inc. (Hayward, CA — other health care — 2022–2023; $106.7M reported sold to 43 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alice Schroeder (2 shared filings), Cem Usakli (2 shared filings), Fred Moll (2 shared filings), Gopinath Kuduvalli (2 shared filings), Greg Garfield (2 shared filings) and 21 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for David Larkin and found 4 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "David Larkin" (NY) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.